Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
10%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
12%
ALSO IN XPH
XPH
55
HOLDINGS
13%
ALSO IN XLV
SECTOR DRIFT (XLV minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.2% | 2.0% | 2.0% |
|
MERCK & CO. INC. | 5.4% | 1.9% | 1.9% |
|
PFIZER INC | 2.8% | 1.7% | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% | 1.7% | 1.7% |
|
JOHNSON & JOHNSON | 10.0% | 1.7% | 1.7% |
XLV Overweight Relative to XPH
|
ELI LILLY & CO | 14.2% |
|
JOHNSON & JOHNSON | 8.4% |
|
ABBVIE INC | 7.1% |
|
UNITEDHEALTH GROUP INC | 6.4% |
|
MERCK & CO. INC. | 3.6% |
|
THERMO FISHER SCIENTIFIC INC | 3.4% |
|
AMGEN INC | 3.4% |
|
GILEAD SCIENCES INC | 3.1% |
|
INTUITIVE SURGICAL INC | 2.8% |
|
ABBOTT LABORATORIES | 2.8% |
XLV Underweight Relative to XPH
|
ORGANON & CO. | -3.8% |
|
CORCEPT THERAPEUTICS INC | -3.7% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.9% |
|
AXSOME THERAPEUTICS, INC. | -2.7% |
|
DEFINIUM THERAPEUTICS INC | -2.4% |
|
ENLIVEN THERAPEUTICS, INC. | -2.3% |
 |
JAZZ PHARMACEUTICALS PLC | -2.3% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
|
TREVI THERAPEUTICS, INC. | -2.1% |
|
ESPERION THERAPEUTICS INC | -2.1% |